Jun Li, MD
Enriched profileCo-Director, Vascular Center and Pulmonary Embolism Response Team (PERT) Program, Harrington Heart & Vascular Institute; Assistant Professor of Medicine, Case Western Reserve University School of Medicine · University Hospitals Harrington Heart & Vascular Institute (Cleveland/Parma, OH); Case Western Reserve University School of Medicine
Jun Li is Co-Director, Vascular Center and Pulmonary Embolism Response Team (PERT) Program, Harrington Heart & Vascular Institute; Assistant Professor of Medicine, Case Western Reserve University School of Medicine at University Hospitals Harrington Heart & Vascular Institute (Cleveland/Parma, OH); Case Western Reserve University School of Medicine. OpenAlex indexes 159 publications with 2,766 citations (h-index 22); ClinicalTrials.gov lists 44 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 1 Sept 2026
Jun Li is Co-Director, Vascular Center and Pulmonary Embolism Response Team (PERT) Program, Harrington Heart & Vascular Institute at University Hospitals Harrington Heart & Vascular Institute (Cleveland/Parma, OH); Case Western Reserve University School of Medicine. The public record shows 159 publications with 2,766 citations (h-index 22), centered on Coronary Artery Disease / ACS, Heart Failure. It also documents an investigator role on 44 registered clinical trials, industry payments reported by 42 companies.
- Most recent indexed publication: 2026 · Vascular medicine (London, England)
- Top research focus: Coronary Artery Disease / ACS
- 44 registered trials on ClinicalTrials.gov
- Open Payments reporting from 42 companies
Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 1 Sept 2026
Listed as an investigator on 44 registered studies on ClinicalTrials.gov. The most recent:
- Colorectal Adenoma Cohort
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- SFEE Diet Management for Gestational Diabetes Mellitus
Sponsor: Ji Jing
Industry payments
Updated 1 Sept 2026
42 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202512 payments
- Medtronic, Inc.Program year202545 payments
- Inquis Medical, Inc.Program year202511 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.4%Statin23%Rosuvastatin Calcium80%Atorvastatin Calcium20%Part D≥71 patientsBeta blocker17.3%Metoprolol Succinate52%Carvedilol31%Metoprolol Tartrate11%Atenolol6%Part D<11 patientsBlood & clotting
25.6%Factor Xa inhibitor12%Eliquis66%Xarelto34%Part D≥22 patientsP2Y12 inhibitor9.7%Clopidogrel100%Part D≥49 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 1 Sept 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Divergent PERTs: A call for unity via harmonized training programs.
Vascular medicine (London, England)
Editorial2026 - Why Age Matters: Revascularization Strategy and Outcomes in Young and Elderly With CLTI.
Circulation. Cardiovascular interventions
Comment2025 - Immunologic profiles in patients with chronic limb-threatening ischemia undergoing endovascular revascularization.
Vascular medicine (London, England)
Article2023 - Proportionate and Absolute Vascular Disease Mortality by Race and Sex in the United States From 1999 to 2019.
Journal of the American Heart Association
Article2022
Online presence
Updated 1 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
scai.org/about-us/scai-staff-listing/jun-li-md-fscai
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗ - LinkedIn
LinkedIn: linkedin.com/in/junlimd (Endovascular Interventional Cardiologist, Co-Director Vascular Center and PERT, Harrington Heart and Vascular Institute, University Hospitals Cleveland)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Doximity
Doximity profile: Dr. Jun Li, MD – Parma, OH, Cardiology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 1 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org ↗
- Board certified: Internal Medicine
Cardiovascular Disease, Interventional Cardiology; Registered Physician in Vascular Interpretation (RPVI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org ↗
Editorial & leadership roles
journal and society appointments- Co-Director
Vascular Center, Harrington Heart & Vascular Institute, University Hospitals
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org ↗ - Co-Director
Pulmonary Embolism Response Team (PERT) Program, University Hospitals
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org ↗ - Member
Vascular Disease Council, Society for Cardiovascular Angiography & Interventions (SCAI)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scai.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhhospitals.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swgeneral.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology